Search the Newsreel

Marine Harvest ASA (MHGVY) to Post Quarterly Earnings on Tuesday

BioHarvest Sciences GAAP EPS of -$0.17 misses by $0.05, revenue of $8.84M misses by $0.61M

* BioHarvest Sciences press release [https://seekingalpha.com/filing/309934017] (BHST [https://seekingalpha.com/symbol/BHST]): Q2 GAAP EPS of -$0.17 misses by $0.05. * Revenue of $8.84M (+3.8% Y/Y) misses by $0.61M. MORE ON BIOHARVEST SCIENCES * BioHarvest Sciences Inc. (BHST) Q1 2026 Earnings Call Transcript [https://seekingalpha.com/article/4904774-bioharvest-sciences-inc-bhst-q1-2026-earnings-call-transcript] * BioHarvest outlines 2026 …

BioHarvest Sciences (NASDAQ: BHST) grows H1 2026 revenue but flags going-concern risk

BioHarvest Sciences reported a modest increase in H1 2026 revenue to $17.344 million, with growth in both its Products and CDMO Services business units. Despite improved liquidity and a stronger balance sheet compared to the previous year, the company flagged substantial doubt about its …

Arvind SmartSpaces to address investors at Equirus India Growth Summit in Mumbai

Great Harvest Maeta Details Audit Fee Basis Ahead of RCHK Reappointment

Select Harvests (ASX:SHV) Shares Outperform in a Softer Sector Session

Why Carvana (CVNA) Is Up 12.1% After Strong Q2 Earnings And Same-Day Delivery Expansion

Artemis Resources Secures Shareholder Backing for Capital-Raising Resolutions

Artemis Resources Reaffirms Existing Exploration Data and Carlow Resource Estimate

Enterprise value to EBITDA forward of Arvinas, Inc. – NASDAQ:ARVN

The article focuses on the enterprise value to EBITDA forward of Arvinas, Inc. (NASDAQ: ARVN), providing financial information and market data for the company. It appears to be a financial data page from TradingView, indicating that the market was closed with no trades at …

Marvell Technology (NASDAQ:MRVL) Shares Down 4.6% - Here's What Happened

Marvell Technology (NASDAQ:MRVL) shares dropped 4.6% to $208.56 on Monday, with trading volume lower than average. Despite the dip, analysts maintain a "Moderate Buy" consensus rating and an average price target of $245.45. The company recently reported strong quarterly revenue and matched EPS estimates, …

Marvell Technology Stock’s Multiple Leans On Profit From Below The Operating Line

Marvell Technology's stock (MRVL) has seen a 191% return over the last year but trades 31% below its 52-week high, with its high trailing price-to-earnings ratio of 76 largely supported by profit generated below the operating line rather than from core operations. While the …

Marvell Technology (MRVL) Commits $250 Million To India Chip R And D Growth

Marvell Technology (MRVL) plans to invest $250 million in India over the next three years to expand its advanced semiconductor R&D, aiming to double its India workforce and boost operations in Bangalore and Hyderabad. This investment will focus on AI, cloud, and data infrastructure …

Here's Why Marvell Technology (MRVL) Fell More Than Broader Market

Marvell Technology (MRVL) shares fell by 4.62%, underperforming the broader market and its sector. The chipmaker has seen a 7.25% loss over the past month. Investors are anticipating its Q3 2026 earnings report on August 27, 2026, with analysts expecting significant year-over-year growth in …

ARVN Maintains by Evercore ISI Group -- Price Target Lowered to $14.00

Evercore ISI Group has maintained an Outperform rating for Arvinas (ARVN) but lowered its price target from $19.00 to $14.00, reflecting a cautious outlook. Despite being significantly undervalued by GuruFocus's GF Value™ at $31.53 versus a current price of $8.95, the company faces financial …

Marvell Technology Inc (MRVL) Shares Fall 4.6% -- What GF Score of 74 Tells Investors

Marvell Technology Inc (MRVL) shares dropped 4.6% to $208.61 on August 10, 2026, despite holding an "above average" GF Score of 74/100. GuruFocus's GF Value estimates the fair value at $114.14, indicating the stock is significantly overvalued by 82.8%. Insider activity shows substantial selling …

Marvell Technology Inc Stock (MRVL) Opened Up by 4.03% on Aug 10: What Signal Does It Send?

Marvell Technology Inc (MRVL) saw its stock open up by 4.03% on August 10th, driven by strong institutional demand for its AI-focused infrastructure and custom silicon solutions, particularly for data center connectivity technologies like 800G and 1.6T. Despite strong growth drivers, the company faces …

What's Going On With Marvell Technology Stock Monday?

Marvell Technology Inc. (NASDAQ: MRVL) stock rose slightly in Monday premarket trading as investors anticipate its upcoming earnings report on August 27th. The company's technical analysis shows mixed signals, with the stock above longer-term moving averages but below its 50-day average, indicating some medium-term …

Arvinas, Inc. Stock 12‑Month Price Target Cut to $13.93, Implies 59% Upside

Arvinas, Inc.'s average 12-month price target has been lowered from $14.23 to $13.93 by 14 analysts, with forecasts ranging from $6 to $21 per share. This new target suggests a potential upside of approximately 59% from the Aug. 7 closing price. The consensus rating …

PensionDanmark Pensionsforsikringsaktieselskab Raises Stake in Carvana Co. $CVNA

Pharvaris N.V. (NASDAQ:PHVS) Receives Consensus Recommendation of "Moderate Buy" from Analysts

Analysts have given Pharvaris N.V. (NASDAQ:PHVS) a "Moderate Buy" consensus recommendation, with an average 12-month price target of $50.08, exceeding its current share price of $34.91. While insider selling has occurred recently, the clinical-stage biotech company, focused on hereditary angioedema with its lead candidate …

Harvard Bioscience Inc (HBIO) Earnings Forecast: Future EPS & Revenue Growth Estimates

Harvard Bioscience Inc (HBIO) has an earnings forecast score of 7.00, ranking 153rd in the Healthcare Equipment & Supplies industry. Analysts have set an average price target of $2.00 with a "Buy" rating based on 2 analysts. The company's expected revenue for the next …

Bioharvest Sciences Inc (BHST) Earnings Forecast: Future EPS & Revenue Growth Estimates

Can Pharvaris (PHVS) Turn AAE-C1INH Patient Insights Into a Lasting Clinical Advantage?

Pharvaris (PHVS) recently published a study detailing the disease burden of acquired C1 inhibitor deficiency (AAE-C1INH) and validating patient-reported outcome tools. This research directly influenced endpoint selection for their Phase 3 CREAATE trial, potentially strengthening future clinical benefit assessments. While this offers a supporting …

Marvell (MRVL) vs. AVGO and NVDA: Can AI Interconnect Growth Deliver the Earnings Its Premium Valuation Demands?

Is MRVL a good stock to buy? We came across a bullish thesis on Marvell Technology, Inc. on Compounding Your Wealth's Substack by Sergey. In this article, we will summarize the bulls' thesis on MRVL. Marvell Technology, Inc.'s share was trading at $211.02 as …

25,500 Shares in Carvana Co. $CVNA Bought by Polianta Ltd

Precision Trading with Arvinas Inc. (ARVN) Risk Zones

This article provides a detailed AI-driven analysis for Arvinas Inc. (ARVN), highlighting potential trading strategies based on sentiment and risk zones. It outlines long, breakout, and short strategies with specific entry points, targets, and stop losses. The analysis also includes multi-timeframe signal strengths and …

Price to book forward of Arvinas, Inc. – NASDAQ:ARVN

This article provides a financial metric, "Price to book forward," for Arvinas, Inc. (NASDAQ:ARVN). It appears to be a stub or a data point from a financial platform, showing the company's ticker, market, and a period value, but without further elaboration or detailed financial …

Benzinga Bulls And Bears: Palantir, Marvell, AppLovin

This Benzinga report reviews the past week's stock market performance, highlighting strong gains in technology, semiconductor, and AI-related companies due to robust earnings and confidence in AI spending. It details bullish reports on Palantir Technologies, Marvell Technology, and IonQ, all of which exceeded expectations …

CVNA Stock Still Presents 32% Upside For RBC Analyst, Even As Retail Gets More Bearish After Q4 Profit Miss

Arvinas (NASDAQ:ARVN) Rating Increased to Hold at Wall Street Zen

Wall Street Zen has upgraded Arvinas (NASDAQ:ARVN) from a "Sell" to a "Hold" rating. This upgrade comes despite mixed analyst sentiments and a forecast for a full-year loss, following a significant quarterly earnings beat where Arvinas reported $2.58 EPS against expected a $0.37 loss …

Arvee Laboratories (India) standalone net profit rises 894.12% in the June 2026 quarter

Marvell Technology Inc (MRVL) Aktienanalyse & Prognose

Arvee Laboratories (India) Ltd is Rated Strong Sell

Arvinas Inc (ARVN) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Arvinas Inc (ARVN), indicating its current earnings forecast score, average price target, and analyst ratings. Based on 17 analysts, the stock has a "Buy" trend with a target price of $14.00, suggesting a potential upside of 61.90%. …

Aarvi Encon Ltd. Earnings and Revenue – BSE:AARVI